BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update
The 2022 Barcelona Clinic Liver Cancer update refines the staging system that links liver cancer stage to treatment, incorporating immunotherapy as first-line systemic therapy, treatment stage migration and a more nuanced view of intermediate-stage disease.
Overview
Update of the BCLC staging and treatment algorithm for hepatocellular carcinoma covering very early, early, intermediate, advanced and terminal stages, with revised recommendations for resection, ablation, transplantation, transarterial therapies, and systemic therapy led by atezolizumab-bevacizumab and durvalumab-tremelimumab, plus the concepts of treatment stage migration and untreatable progression.
The BCLC stages used on this site's hepatocellular carcinoma pages and their default treatments follow this update.
- Combination of locoregional and systemic therapy for intermediate disease (EMERALD-1, LEAP-012) postdates the update.
Similar pages
not linked directly; found by shared links- TermLI-RADS (Liver Imaging Reporting and Data System)
Shares Intermediate hepatocellular carcinoma (BCLC B), Early hepatocellular carcinoma (BCLC 0 and A), Advanced hepatocellular carcinoma (BCLC C).
- Key paperHIMALAYA: tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
Shares Intermediate hepatocellular carcinoma (BCLC B), Advanced hepatocellular carcinoma (BCLC C).
- TermBridging therapy
Shares Intermediate hepatocellular carcinoma (BCLC B), Early hepatocellular carcinoma (BCLC 0 and A).
- TrialHIMALAYA
Shares Intermediate hepatocellular carcinoma (BCLC B), Advanced hepatocellular carcinoma (BCLC C).
- TrialIMbrave150
Shares Intermediate hepatocellular carcinoma (BCLC B), Advanced hepatocellular carcinoma (BCLC C).
- TermHepatitis B and C as cancer causes
Shares Early hepatocellular carcinoma (BCLC 0 and A), Advanced hepatocellular carcinoma (BCLC C).
- TechnologyRadioembolisation (TARE / SIRT, yttrium-90)
Shares Intermediate hepatocellular carcinoma (BCLC B), Early hepatocellular carcinoma (BCLC 0 and A), Advanced hepatocellular carcinoma (BCLC C).
- TermBCLC staging
Shares Intermediate hepatocellular carcinoma (BCLC B), Early hepatocellular carcinoma (BCLC 0 and A).